Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate vs. Deferred ART in HIV-Associated Tuberculous Meningitis
NCT00433719Phase 4Unknown
- Sponsor
- University of Oxford
- Start
- Sep 2005
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zidovudine + lamivudine + efavirenz in human immunodeficiency virus infection (HIV), sponsored by University of Oxford. Status: unknown.
02
Drugs
zidovudine + lamivudine + efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00433719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433719.